Skip to main content
SpringerLink
Log in

Kommentar zum Konsensuspapier zur prähospitalen Behandlung des akuten Koronarsyndroms bei Patienten unter Dauertherapie mit neuen oralen Antikoagulanzien (NOAK)

Comments on the German consensus statement on prehospital treatment of acute coronary syndrome in patients under long-term treatment with novel oral anticoagulants (NOAC)

  • Leitlinien und Empfehlungen
  • Published:
Der Anaesthesist Aims and scope Submit manuscript

Zusammenfassung

Trotz einer zunehmenden Anzahl von Patienten, welche unter einer Dauertherapie mit neuen oralen Antikoagulanzien ein akutes Koronarsyndrom erleiden, existierten bisher keine Handlungsempfehlungen für deren prähospitale antikoagulatorische Therapie. Aus diesem Grund formulierten die Deutsche Gesellschaft für Kardiologie und die Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin ein Konsensuspapier zur Therapie dieser speziellen Patientengruppe. Um die Sicherheit dieses Patientenkollektives zu erhöhen, ist es Ziel des Konsensuspapiers, die aktuelle Evidenzlage in strukturierten Empfehlungen zusammenzufassen.

Abstract

Despite an increasing number of patients suffering from an acute coronary syndrome under novel oral anticoagulant therapy, specific treatment recommendations for anticoagulation are still lacking. For this reason, the German Society of Cardiology and the German Association of Interdisciplinary Intensive Care and Emergency Medicine developed a consensus statement for the treatment of these patients with the aim to summarize the current evidence and to increase the safety of this special patient group.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Abu-Assi E, Raposeiras-Roubin S, Lear P et al (2012) Comparing the predictive validity of three contemporary bleeding risk scores in acute coronary syndrome. Eur Heart J Acute Cardiovasc Care 1:222–231. https://doi.org/10.1177/2048872612453924

    Article  PubMed  PubMed Central  Google Scholar 

  2. Antman EM, Cohen M, Bernink PJ et al (2000) The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 284:835–842. https://doi.org/10.1001/jama.284.7.835

    Article  CAS  PubMed  Google Scholar 

  3. Avezum A, Lopes RD, Schulte PJ et al (2015) Apixaban in comparison with warfarin in patients with atrial fibrillation and valvular heart disease: findings from the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial. Circulation 132:624–632. https://doi.org/10.1161/CIRCULATIONAHA.114.014807

    Article  CAS  PubMed  Google Scholar 

  4. Chen J‑Y, He P‑C, Liu Y‑H et al (2019) Association of parenteral anticoagulation therapy with outcomes in Chinese patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndrome. JAMA Intern Med 179:186–194. https://doi.org/10.1001/jamainternmed.2018.5953

    Article  PubMed  Google Scholar 

  5. Collet J‑P, Thiele H, Barbato E et al (2020) 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. https://doi.org/10.1093/eurheartj/ehaa575

    Article  PubMed  PubMed Central  Google Scholar 

  6. Goto K, Nakai K, Shizuta S et al (2014) Anticoagulant and antiplatelet therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention. Am J Cardiol 114:70–78. https://doi.org/10.1016/j.amjcard.2014.03.060

    Article  CAS  PubMed  Google Scholar 

  7. Hamm CW, Schneck E, Buerke M et al (2021) Empfehlungen zur prähospitalen Behandlung des akuten Koronarsyndroms bei Patienten unter Dauertherapie mit neuen oralen Antikoagulanzien (NOAKs). Kardiologe. https://doi.org/10.1007/s12181-020-00439-4

    Article  Google Scholar 

  8. Ibanez B, James S, Agewall S et al (2018) 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 39:119–177. https://doi.org/10.1093/eurheartj/ehx393

    Article  PubMed  Google Scholar 

  9. Kemkes-Matthes B (2017) Antikoagulation – direkte orale Antikoagulanzien. Internist 58:585–597. https://doi.org/10.1007/s00108-017-0243-y

    Article  CAS  PubMed  Google Scholar 

  10. Kirchhof P, Benussi S, Kotecha D et al (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37:2893–2962. https://doi.org/10.1093/eurheartj/ehw210

    Article  PubMed  Google Scholar 

  11. Konstantinides SV, Meyer G (2019) The 2019 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 40:3453–3455. https://doi.org/10.1093/eurheartj/ehz726

    Article  PubMed  Google Scholar 

  12. Kralev S, Schneider K, Lang S et al (2011) Incidence and severity of coronary artery disease in patients with atrial fibrillation undergoing first-time coronary angiography. Plos One 6:e24964. https://doi.org/10.1371/journal.pone.0024964

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Nieuwlaat R, Capucci A, Camm AJ et al (2005) Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. Eur Heart J 26:2422–2434. https://doi.org/10.1093/eurheartj/ehi505

    Article  PubMed  Google Scholar 

  14. Patel MR, Mahaffey KW, Garg J et al (2011) Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 365:883–891. https://doi.org/10.1056/NEJMoa1009638

    Article  CAS  PubMed  Google Scholar 

  15. Roule V, Ardouin P, Briet C et al (2019) Vitamin K antagonist vs direct oral anticoagulants with antiplatelet therapy in dual or triple therapy after percutaneous coronary intervention or acute coronary syndrome in atrial fibrillation: meta-analysis of randomized controlled trials. Clin Cardiol. https://doi.org/10.1002/clc.23224

    Article  PubMed  PubMed Central  Google Scholar 

  16. Ruff CT, Giugliano RP, Antman EM et al (2010) Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infar. Am Heart J 160:635–641. https://doi.org/10.1016/j.ahj.2010.06.042

    Article  CAS  PubMed  Google Scholar 

  17. Schneck E, Schneck FK, Wolter JS et al (2020) Prehospital management of acute coronary syndrome in patients on long-term direct oral anticoagulant treatment. Anaesthesist 69:108–116. https://doi.org/10.1007/s00101-019-00710-8

    Article  CAS  PubMed  Google Scholar 

  18. Subherwal S, Bach RG, Chen AY et al (2009) Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score. Circulation 119:1873–1882. https://doi.org/10.1161/CIRCULATIONAHA.108.828541

    Article  PubMed  PubMed Central  Google Scholar 

  19. Thygesen K, Alpert JS, Jaffe AS et al (2019) Fourth universal definition of myocardial infarction (2018). Eur Heart J 40:237–269. https://doi.org/10.1093/eurheartj/ehy462

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Anästhesiologie, operative Intensivmedizin und Schmerztherapie, Universitätsklinikum Gießen und Marburg, Standort Gießen, Justus-Liebig-Universität Gießen, Rudolf-Buchheim-Straße 7, 35392, Gießen, Deutschland

    Emmanuel Schneck, Christian Koch & Michael Sander

  2. Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin (DIVI e. V.), Berlin, Deutschland

    Emmanuel Schneck, Daniel Dirkmann, Christian Koch & Michael Sander

  3. Medizinische Klinik I (Kardiologie und Angiologie), Universitätsklinikum Gießen und Marburg, Standort Gießen, Gießen, Deutschland

    Christian W. Hamm

  4. Klinik für Kardiologie, Kerckhoff Klinik, Bad Nauheim, Deutschland

    Christian W. Hamm, Franziska Schneck & Jan Sebastian Wolter

  5. Deutsche Gesellschaft für Kardiologie (DGK e. V.), Düsseldorf, Deutschland

    Christian W. Hamm, Franziska Schneck & Jan Sebastian Wolter

  6. Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie, Alfried Krupp Krankenhaus, Essen, Deutschland

    Daniel Dirkmann

Authors
  1. Emmanuel Schneck
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christian W. Hamm
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Franziska Schneck
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jan Sebastian Wolter
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Daniel Dirkmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Christian Koch
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Michael Sander
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Emmanuel Schneck.

Ethics declarations

Interessenkonflikt

E. Schneck, C.W. Hamm, F. Schneck, J.S. Wolter, D. Dirkmann, C. Koch und M. Sander geben an, dass kein Interessenkonflikt besteht.

Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schneck, E., Hamm, C.W., Schneck, F. et al. Kommentar zum Konsensuspapier zur prähospitalen Behandlung des akuten Koronarsyndroms bei Patienten unter Dauertherapie mit neuen oralen Antikoagulanzien (NOAK). Anaesthesist 70, 785–788 (2021). https://doi.org/10.1007/s00101-021-00943-6

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00101-021-00943-6

Schlüsselwörter

Keywords

Search

Navigation